Regulating Flexibility for Artificial Intelligence FDA Experience with Predetermined Change Control Plans
Kyra L. Rosen, View ORCID ProfileKenneth D. Mandl
doi: https://doi.org/10.1101/2025.08.26.25334477
Kyra L. Rosen
1Computational Health Informatics Program, Boston Children’s Hospital, Boston, MA
2Harvard Medical School, Boston, MA
BAKenneth D. Mandl
1Computational Health Informatics Program, Boston Children’s Hospital, Boston, MA
3Departments of Pediatrics and Biomedical Informatics, Harvard Medical School, Boston, MA
MD MPH
Data Availability
All data presented in the study are publicly available.
Posted August 27, 2025.
Regulating Flexibility for Artificial Intelligence FDA Experience with Predetermined Change Control Plans
Kyra L. Rosen, Kenneth D. Mandl
medRxiv 2025.08.26.25334477; doi: https://doi.org/10.1101/2025.08.26.25334477
Subject Area
Subject Areas
- Addiction Medicine (576)
- Allergy and Immunology (868)
- Anesthesia (306)
- Cardiovascular Medicine (4482)
- Dermatology (385)
- Emergency Medicine (614)
- Epidemiology (15277)
- Forensic Medicine (31)
- Gastroenterology (1133)
- Genetic and Genomic Medicine (6644)
- Geriatric Medicine (671)
- Health Economics (1006)
- Health Informatics (4603)
- Health Policy (1378)
- Hematology (544)
- HIV/AIDS (1276)
- Medical Education (626)
- Medical Ethics (147)
- Nephrology (674)
- Neurology (6695)
- Nursing (346)
- Nutrition (1006)
- Obstetrics and Gynecology (1153)
- Oncology (3369)
- Ophthalmology (988)
- Orthopedics (370)
- Otolaryngology (421)
- Pain Medicine (437)
- Palliative Medicine (131)
- Pathology (669)
- Pediatrics (1704)
- Primary Care Research (717)
- Public and Global Health (9285)
- Radiology and Imaging (2223)
- Respiratory Medicine (1201)
- Rheumatology (598)
- Sports Medicine (535)
- Surgery (722)
- Toxicology (100)
- Transplantation (290)
- Urology (267)




